MACI (Vericel Corporation)
Welcome to the PulseAid listing for the MACI drug offered from Vericel Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
LABELER NAME / MANUFACTURER: | Vericel Corporation |
NON-PROPRIETARY NAME: | autologous cultured chondrocytes |
SUBSTANCE NAME: | AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN |
TYPE: | CELLULAR THERAPY |
PHARMA CLASS: | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] |
ROUTE: | INTRA-ARTICULAR |
DOSAGE FORM: | IMPLANT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-01-11 |
END MARKETING DATE: | 0000-00-00 |
MACI CELLULAR THERAPY Details:
Item Description | MACI from Vericel Corporation |
LABELER NAME: | Vericel Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15000000; 15(1/1; cm2/1) |
START MARKETING DATE: | 2017-01-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69866-1030_a6afee99-4a95-4488-84d8-7bdea7e9bbe3 |
PRODUCT NDC: | 69866-1030 |
APPLICATION NUMBER: | BLA125603 |
Other AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN Pharmaceutical Manufacturers / Labelers: